Mary O’Hearn

1.3k total citations · 1 hit paper
9 papers, 838 citations indexed

About

Mary O’Hearn is a scholar working on Virology, Infectious Diseases and Oncology. According to data from OpenAlex, Mary O’Hearn has authored 9 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Virology, 3 papers in Infectious Diseases and 2 papers in Oncology. Recurrent topics in Mary O’Hearn's work include HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV/AIDS Research and Interventions (2 papers). Mary O’Hearn is often cited by papers focused on HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV/AIDS Research and Interventions (2 papers). Mary O’Hearn collaborates with scholars based in United States, Australia and United Kingdom. Mary O’Hearn's co-authors include Jain Chung, Keith Henry, Miklos Salgo, Joseph J. Eron, John Delehanty, Peter J. Piliero, Jacob Lalezari, Sharon Walmsley, Benoît Trottier and Calvin Cohen and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and Annals of the New York Academy of Sciences.

In The Last Decade

Mary O’Hearn

7 papers receiving 799 citations

Hit Papers

Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistan... 2003 2026 2010 2018 2003 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America
    2003 716 citations Jacob Lalezari, Keith Henry et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary O’Hearn United States 6 676 599 136 115 106 9 838
F de Wolf Netherlands 10 484 0.7× 759 1.3× 234 1.7× 286 2.5× 106 1.0× 20 945
Debra P. Merrill United States 12 558 0.8× 573 1.0× 132 1.0× 94 0.8× 89 0.8× 16 742
Steve Felstead United Kingdom 2 411 0.6× 457 0.8× 138 1.0× 103 0.9× 68 0.6× 2 605
Julie Lewis United Kingdom 6 375 0.6× 737 1.2× 222 1.6× 464 4.0× 95 0.9× 6 958
Marina Korneyeva United States 5 566 0.8× 525 0.9× 56 0.4× 33 0.3× 99 0.9× 7 702
Roberta D’Arrigo Italy 20 717 1.1× 735 1.2× 160 1.2× 75 0.7× 261 2.5× 37 957
Carey Hwang United States 20 802 1.2× 665 1.1× 396 2.9× 117 1.0× 188 1.8× 49 1.2k
Margrit Carlson United States 8 311 0.5× 296 0.5× 177 1.3× 35 0.3× 76 0.7× 15 537
Heribert Knechten Germany 15 512 0.8× 435 0.7× 170 1.3× 27 0.2× 52 0.5× 44 691
Jayvant Heera United States 18 700 1.0× 771 1.3× 254 1.9× 146 1.3× 97 0.9× 43 992

Countries citing papers authored by Mary O’Hearn

Since Specialization
Citations

This map shows the geographic impact of Mary O’Hearn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary O’Hearn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary O’Hearn more than expected).

Fields of papers citing papers by Mary O’Hearn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary O’Hearn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary O’Hearn. The network helps show where Mary O’Hearn may publish in the future.

Co-authorship network of co-authors of Mary O’Hearn

This figure shows the co-authorship network connecting the top 25 collaborators of Mary O’Hearn. A scholar is included among the top collaborators of Mary O’Hearn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary O’Hearn. Mary O’Hearn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
O’Hearn, Mary, Jain Chung, Peter J. Piliero, et al.. (2020). Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America. UNC Libraries.
2.
O’Hearn, Mary, et al.. (2012). Chronic Ulcerative Herpes Simplex Virus Infection of the Vulva. Case Reports in Dermatology. 4(3). 192–196. 1 indexed citations
3.
Cooper, DA, Peter Reiss, Keith Henry, et al.. (2010). The effects of enfuvirtide therapy on body composition and metabolic parameters over 48 weeks in the TORO body imaging substudy*. HIV Medicine. 12(1). 31–39. 12 indexed citations
4.
Lalezari, Jacob, Keith Henry, Mary O’Hearn, et al.. (2003). Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America. New England Journal of Medicine. 348(22). 2175–2185. 716 indexed citations breakdown →
5.
O’Hearn, Mary, et al.. (2003). Fatal Lactic Acidosis and Acute Renal Failure after Addition of Tenofovir to an Antiretroviral Regimen Containing Didanosine. Clinical Infectious Diseases. 36(8). 1082–1085. 77 indexed citations
6.
Waldor, Matthew K., et al.. (1987). Treatment of Experimental Autoimmune Myasthenia Gravis with Monoclonal Antibodies to Immune Response Gene Productsa. Annals of the New York Academy of Sciences. 505(1). 655–668. 6 indexed citations
7.
Steinman, Lawrence, et al.. (1984). Gene specific and antigen specific strategies for the induction of suppressor T cells to myelin basic protein.. PubMed. 146. 393–7.
8.
O’Hearn, Mary & Daniel P. Stites. (1983). Inhibition of murine suppressor cell function by progesterone. Cellular Immunology. 76(2). 340–350. 11 indexed citations
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F de Wolf Breakdown of academic impact, for papers by Debra P. Merrill Breakdown of academic impact, for papers by Steve Felstead Breakdown of academic impact, for papers by Julie Lewis Breakdown of academic impact, for papers by Marina Korneyeva Breakdown of academic impact, for papers by Roberta D’Arrigo Breakdown of academic impact, for papers by Carey Hwang Breakdown of academic impact, for papers by Margrit Carlson Breakdown of academic impact, for papers by Heribert Knechten Breakdown of academic impact, for papers by Jayvant Heera
Rankless by CCL
2026